Home » Newsletters » BioWorld

BioWorld

May 27, 1993

View Archived Issues

NIH BUDGET FACES UPHILL BATTLE

NPS TO SEEK NOVEL DRUGS IN MADAGASCAR

CEO OF TWO VC FIRMS DIES

VANGUARD'S STRATEGY: DEVELOPING CASTOFFS

APPOINTMENTS AND ADVANCEMENTS

LIPOSOME TECH. ISSUED PATENT

NABI'S EUROPEAN PATENT FOR HIVIG ALLOWED

EUROPEAN DEAL WORTH $14M TO GENELABS

ENVIROGEN STARTS PCB FIELD TRIALS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...